Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Alp, Keziban Merve (1) Besser, Daniel Dr. (1) Birchmeier, Walter Prof. Dr. (7) Blankenstein, Thomas Prof. Dr. (2) Blüthgen, Nils (1) Dahlmann, Mathias Dr. (29) Daniel, Peter Prof. Dr. (3) Fritsche, Raphaela Dr. (2) Hartl, Kimberly (1) Herse, Florian PD Dr. (1) Hübner, Norbert Prof. Dr. (1) Ivics, Zoltan Dr. (2) Izsvak, Zsuzsanna Dr. (2) Janke, Jürgen Dr. (1) Janz, Martin Dr. (1) Keller, Ulrich Dr. med. (1) Kobelt, Dennis Dr. (51) Koch, Gudrun (1) Leutz, Achim Prof. Dr. (2) Malchin, Victoria (1) Mertins, Philipp Dr. (4) Na, Il-Kang Dr. (1) Nazare, Marc (1) Nguyen, Tam Hoai Dr. (1) Nimptsch, Katharina Dr. (1) Pezzutto, Antonio Prof. Dr. (3) Pischon, Tobias Prof. Dr. (1) Popp, Oliver Dr. (3) Ramberger, Evelyn (1) Rathjen, Fritz Prof. Dr. (1) Rehm, Armin Dr. (1) Röefzaad, Claudia (1) Schmitt, Clemens Prof. Dr. (2) Schöpe, Paul Curtis (2) Schroeder, Leif Dr. (1) Simon, Mareike Dr. (1) Smith, Janice (16) Specker, Edgar Dr. (2) Sperling, Silke Prof. Dr. (1) Sporbert, Anje Dr. (1) Stein, Ulrike Prof. Dr. (186) Torke, Sebastian Dr. (2) Uckert, Wolfgang Prof. Dr. (1) Veltsista, Paraskevi Danai (1) von Kries, Jens Peter Dr. (2) Walther, Wolfgang Prof. Dr. (143) Wenzel, Katrin Dr. (1) Willimsky, Gerald Dr. (1) Willnow, Thomas Prof. Dr. (1) Wolf, Jana Prof. Dr. (1) Zimmermann, Karin Dr. (1) (-) Schlag, Peter M. Prof. Dr. (378) Entwicklungsneurobiologie (1) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Molekulare Herz- Kreislaufforschung (1) Molekulare Immunologie und Gentherapie (1) (-) Translationale Onkologie solider Tumore (378) 1996 (2) 1998 (3) 1999 (10) 2000 (8) 2001 (40) 2002 (55) 2003 (31) 2004 (23) 2005 (24) 2006 (24) 2007 (29) 2008 (32) 2009 (30) 2010 (16) 2011 (12) 2012 (19) 2013 (11) 2014 (2) 2015 (3) 2016 (2) 2017 (1) 2023 (1) 378 Ergebnisse: Active Filter: Schlag, Peter M. Prof. Dr.Translationale Onkologie solider Tumore Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 08. Dezember 2023 / Front Oncol GIPC1 regulates MACC1-driven metastasis F. Siegel H. Schmidt M. Juneja J. Smith P. Herrmann D. Kobelt K. Sharma I. Fichtner W. Walther G. Dittmar R. Volkmer F.G. Rathjen P.M. Schlag U. Stein 01. Juni 2017 / PLoS Biol Statin and rottlerin small-molecule inhibitors restrict colon cancer progression and metastasis via MACC1 M. Juneja D. Kobelt W. Walther C. Voss J. Smith E. Specker M. Neuenschwander B.O. Gohlke M. Dahlmann S. Radetzki R. Preissner J.P. von Kries P.M. Schlag U. Stein 01. Dezember 2016 / J Mol Med C/EBPβ regulates homeostatic and oncogenic gastric cell proliferation G. Regalo S. Förster C. Resende B. Bauer B. Fleige W. Kemmner P.M. Schlag T.F. Meyer J.C. Machado A. Leutz 17. November 2016 / Oncogene SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival F. Schmid Q. Wang M.R. Huska M.A. Andrade-Navarro M. Lemm I. Fichtner M. Dahlmann D. Kobelt W. Walther J. Smith P.M. Schlag U. Stein 01. November 2015 / Eur J Cancer Prognostic impact of immune response in resectable colorectal liver metastases treated by surgery alone or surgery with perioperative FOLFOX in the randomised EORTC study 40983 E. Tanis C. Julie J.F. Emile M. Mauer B. Nordlinger D. Aust A. Roth M.P. Lutz T. Gruenberger F. Wrba H. Sorbye W. Bechstein P. Schlag A. Fisseler T. Ruers 01. September 2015 / Hepatology Metastasis-associated in colon cancer 1 is an independent prognostic biomarker for survival in klatskin tumor patients A. Lederer P. Herrmann D. Seehofer M. Dietel J. Pratschke P. Schlag U. Stein 14. Februar 2015 / Mol Cancer High MACC1 expression in combination with mutated KRAS G13 indicates poor survival of colorectal cancer patients K. Ilm W. Kemmner M. Osterland S. Burock G. Koch P. Herrmann P.M. Schlag U. Stein 30. Mai 2014 / Oncotarget RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis M. Dahlmann A. Okhrimenko P. Marcinkowski M. Osterland P. Herrmann J. Smith C.W. Heizmann P.M. Schlag U. Stein 01. Mai 2014 / Mol Oncol Preclinical study on combined chemo- and nonviral gene therapy for sensitization of melanoma using a human TNF-alpha expressing MIDGE DNA vector D. Kobelt J. Aumann M. Schmidt B. Wittig I. Fichtner D. Behrens M. Lemm G. Freundt P.M. Schlag W. Walther 01. Dezember 2013 / Onkologe Klinische und epidemiologische Krebsregister : Krebsregister in Deutschland – quo vadis? [Clinical and epidemiological Cancer Registers Cancer Registers in Germany - quo vadis?] G. Moeslein J. Haier P.M. Schlag Seitennummerierung Aktuelle Seite 1 Seite 2 Seite 3 Seite 4 … Nächste Seite Next › Letzte Seite Last »
08. Dezember 2023 / Front Oncol GIPC1 regulates MACC1-driven metastasis F. Siegel H. Schmidt M. Juneja J. Smith P. Herrmann D. Kobelt K. Sharma I. Fichtner W. Walther G. Dittmar R. Volkmer F.G. Rathjen P.M. Schlag U. Stein
01. Juni 2017 / PLoS Biol Statin and rottlerin small-molecule inhibitors restrict colon cancer progression and metastasis via MACC1 M. Juneja D. Kobelt W. Walther C. Voss J. Smith E. Specker M. Neuenschwander B.O. Gohlke M. Dahlmann S. Radetzki R. Preissner J.P. von Kries P.M. Schlag U. Stein
01. Dezember 2016 / J Mol Med C/EBPβ regulates homeostatic and oncogenic gastric cell proliferation G. Regalo S. Förster C. Resende B. Bauer B. Fleige W. Kemmner P.M. Schlag T.F. Meyer J.C. Machado A. Leutz
17. November 2016 / Oncogene SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival F. Schmid Q. Wang M.R. Huska M.A. Andrade-Navarro M. Lemm I. Fichtner M. Dahlmann D. Kobelt W. Walther J. Smith P.M. Schlag U. Stein
01. November 2015 / Eur J Cancer Prognostic impact of immune response in resectable colorectal liver metastases treated by surgery alone or surgery with perioperative FOLFOX in the randomised EORTC study 40983 E. Tanis C. Julie J.F. Emile M. Mauer B. Nordlinger D. Aust A. Roth M.P. Lutz T. Gruenberger F. Wrba H. Sorbye W. Bechstein P. Schlag A. Fisseler T. Ruers
01. September 2015 / Hepatology Metastasis-associated in colon cancer 1 is an independent prognostic biomarker for survival in klatskin tumor patients A. Lederer P. Herrmann D. Seehofer M. Dietel J. Pratschke P. Schlag U. Stein
14. Februar 2015 / Mol Cancer High MACC1 expression in combination with mutated KRAS G13 indicates poor survival of colorectal cancer patients K. Ilm W. Kemmner M. Osterland S. Burock G. Koch P. Herrmann P.M. Schlag U. Stein
30. Mai 2014 / Oncotarget RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis M. Dahlmann A. Okhrimenko P. Marcinkowski M. Osterland P. Herrmann J. Smith C.W. Heizmann P.M. Schlag U. Stein
01. Mai 2014 / Mol Oncol Preclinical study on combined chemo- and nonviral gene therapy for sensitization of melanoma using a human TNF-alpha expressing MIDGE DNA vector D. Kobelt J. Aumann M. Schmidt B. Wittig I. Fichtner D. Behrens M. Lemm G. Freundt P.M. Schlag W. Walther
01. Dezember 2013 / Onkologe Klinische und epidemiologische Krebsregister : Krebsregister in Deutschland – quo vadis? [Clinical and epidemiological Cancer Registers Cancer Registers in Germany - quo vadis?] G. Moeslein J. Haier P.M. Schlag